The FDA's warning letter dated July 1 comes months after several Indian drugmakers including Sun Pharmaceutical Ltd and Dr. Reddy's Laboratories Ltd were named in a US lawsuit against Israeli drugmaker Teva Pharmaceutical Industries Ltd accusing it of conspiring to inflate drug prices and stifle competition for generic drugs.